Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
424.00
0.00 (0.00%)
At close: Jan 13, 2026
Roche Holding AG Revenue
Roche Holding AG had revenue of 31.85B CHF in the half year ending June 30, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 63.49B, up 4.80% year-over-year. In the year 2024, Roche Holding AG had annual revenue of 62.40B with 3.23% growth.
Revenue (ttm)
63.49B CHF
Revenue Growth
+4.80%
P/S Ratio
4.65
Revenue / Employee
614.90K CHF
Employees
103,249
Market Cap
371.17B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
Roche Holding AG News
- 3 days ago - Goldman Sachs Upgrades Roche (RHHBY) Amid Growth Prospects - GuruFocus
- 3 days ago - Roche upgraded at Goldman Sachs on reduced catalyst risks - Seeking Alpha
- 5 days ago - BGI, Roche roll out diagnostic tests for Alzheimer's in China - Reuters
- 9 days ago - ClearBridge Dividend Strategy Fund adds PCG, RHHBY, exits EIX, MRK among Q4 moves - Seeking Alpha
- 10 days ago - The Zacks Analyst Blog Highlights Micron Technology, Roche and UnitedHealth - Nasdaq
- 11 days ago - Top Stock Reports for Micron Technology, Roche & UnitedHealth - Nasdaq
- 18 days ago - What's Going On With Royalty Pharma Stock Wednesday? - Benzinga
- 20 days ago - Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics - Nasdaq